Novo Nordisk last week cut its full-year guidance and named Mike Doustdar as its new CEO.
Novo Nordisk’s Wegovy weight loss drug sales soar 67% in second quarter
Related Posts
Microsoft rallies in last 10 minutes of trading to avoid first eight-week losing streak since 2008
Microsoft faces competition in cloud computing from companies such as Google, which is looking to boost its security business with…
‘Good chance’ of UK-U.S. trade deal, JD Vance says, as Trump ‘really loves’ Britain
“I think there’s a good chance that, yes, we’ll come to a great agreement that’s in the best interest of…
New capabilities in Amazon SageMaker AI continue to transform how organizations develop AI models
As AI models become increasingly sophisticated and specialized, the ability to quickly train and customize models can mean the difference…